{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-021511","form_type":"8-K","ticker":"LFST","cik":"0001845257","company_name":"LifeStance Health Group, Inc.","filed_at":"2024-02-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.960541+00:00","generated_at":"2026-06-05T09:29:23.733851+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"LifeStance Q4 revenue $280.6M (+22% YoY); net loss $45M; guides FY24 revenue $1.19-$1.24B","bullets":["Q4 revenue $280.6M (+22% YoY); full-year revenue $1,055.7M (+23%).","Q4 net loss $45.0M; full-year net loss $186.3M. Adjusted EBITDA $20.3M (Q4) and $59.0M (FY).","Added 227 net clinicians in Q4, 1,014 in FY; total clinicians 6,645 (+18% YoY).","FY2024 guidance: revenue $1.19-$1.24B, Center Margin $345-$365M, Adj. EBITDA $80-$90M, positive free cash flow."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-021511","json":"https://secwatch.observer/filing/0000950170-24-021511.json","markdown":"https://secwatch.observer/filing/0000950170-24-021511.md","text":"https://secwatch.observer/filing/0000950170-24-021511.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024021511/0000950170-24-021511-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024021511/lfst-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T09:29:23.733851+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"38a901d423bccb9ac0a5394ea13973f8ec2124d8","claim":"LifeStance Health Group, Inc. reported the fourth quarter and full year ended December 31, 2023 results: revenue $280.6 million, net income Net loss of $45.0 million. Guidance initiated.","evidence_excerpt":"full year ended December 31, 2023. (All results compared to prior-year comparative period, unless otherwise noted) 2023 Highlights and 2024 Outlook • Fourth quarter revenue of $280.6 million increased 22% and full year revenue of $1,055.7 million increased 23% compared to revenue of $859.5 million • Clinician base increased 18% to 6,645 clinicians, including 227 net","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1845257/000095017024021511/0000950170-24-021511-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2023"},{"label":"Revenue","value":"$280.6 million"},{"label":"Net income","value":"Net loss of $45.0 million"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}